Using Choosing Wisely, AAP, and CDC recommendations as a foundation, the faculty will review the evidence-based guidelines for the following topics: diagnosis/management of upper respiratory infections (e.g., otitis media), the efficacy of PPI/H2B in young children, the new updates in blood pressure screening, universal HIV screening in adolescents, and mental health tools that assist in screening for depression, anxiety, and ADHD.
This presentation will review new vaccines available in the U.S. market and newer formulations of previously available vaccines. A discussion on the pros and cons of their administration and their place in the primary care provider’s practice will help clinicians more effectively manage vaccines for their patients.
Adolescence is a period of tremendous growth and development, not only physically but emotionally and psychosocially. Understanding the health care issues unique to adolescents and how to best approach these issues will benefit both the health care provider and the adolescent patient. We will look at cases that highlight some problems that primary care providers may encounter in their practices.
Globally, human papilloma viruses (HPV) are responsible for virtually 100% of cervical cancers, 75% of vaginal cancers, 69% of vulvar cancers, 91% of anal cancers, 63% of penile cancers, approximately 70% of oropharyngeal cancers, and almost all cases of genital warts. This activity provides an update on the prevention of HPV-related cancers and the newly expanded vaccine indications.
The AAP released new guidelines for the screening and management of high BP in children and teens in 2017. The last recommendations were published in 2004. Join us as we discuss these updated recommendations and their impact on your practice.
Kids love fruit juice. But how much is OK? What are the facts on fruit juice consumption in kids and what should you advise the families you care for? In this episode, we will discuss the latest recommendations from the American Academy of Pediatrics and how they may impact your practice.
Both the WHO and AAP recommend exclusive breastfeeding until 6 months of age then solids and breast milk until 12 months of age. The well-established benefits of breastfeeding include support of infant growth and development of immunity. Recently, a clinical trial from the UK found an association between the early introduction of foods and infant sleep. Join us while we discuss the findings of this study and possible implications to your care of moms and their infants.
Measles were declared eliminated in 2000; however, in June 2019, the CDC announced that there were > 1,000 cases identified in the US—the largest number of cases since 1992. Join us as we discuss the causes of this increase in a vaccine-preventable disease (VPD) and strategies for containing this looming public health concern.
Reading to young children is a well-established activity that can impact neuro-cognitive and emotional development in children. Since many parents use E-readers and other digital platforms to read to their kids, in this episode we will explore whether there is a difference or benefit to using a particular type of book. Join us as we discuss the recent findings on parent-toddler interactions when reading from a print book versus an E-reader.
Sexting is increasing among U.S. youth. As cellular technology evolves, so does the behavior. There is some evidence that can help inform teens and their parents of risk, which includes increased risk of high-risk sexual behavior and non-consensual sharing of personal digital data. This episode provides clinicians important evidence on teens and sexting to inform their care of teens and their families.
Growth is a fundamental process of childhood that is followed longitudinally by primary care. Poor growth velocity warrants an evaluation to identify an underlying pathology, whether endocrine or non-endocrine, whereas short stature refers to height below the normal spectrum of the population. You will learn more about common pathologies that may present with poor growth and contrast them with genetic mechanisms that contribute to variation in the population. Growth hormone—which was traditionally restricted to use in those with growth hormone deficiency—is the main intervention available to increase final adult height. As it commonly has efficacy to increase stature outside of the setting of growth hormone deficiency, the number of FDA-approved indications for its use have expanded over the past decades. The faculty in this lecture will also discuss considerations by pediatric endocrinologists in the prescription of growth hormone.